Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Archer Materials ( (AU:AXE) ).
Archer Materials reported progress in Q3 FY26 across its quantum computing and sensing platforms, advancing development of a carbon-based qubit device by improving readout and control via single-electron transistors and scaling carbon material growth to wafer-level fabrication. The company deepened its collaboration with Emergence Quantum and EPFL to accelerate graphene and carbon film device development, positioning Archer closer to a demonstrator qubit and potential commercial engagements with quantum system builders.
In quantum-enabled software, Archer completed the first phase of its Quantum Machine Learning models aimed at enhancing fraud detection in financial transactions and is targeting a full prototype by year-end. The company’s Biochip program also reached a key milestone with an alpha-prototype blood potassium sensor meeting clinical accuracy and stability standards, supporting plans for a beta-prototype, clinical trials, expanded diagnostic applications, and multiple commercialisation pathways backed by a $10.3 million cash position and no debt.
More about Archer Materials
Archer Materials Limited is an Australian quantum technology company focused on developing hardware and software for quantum computing, sensing, and medical diagnostics. The company is working with carbon-based materials and graphene to build qubit devices and biochips, targeting applications in fraud detection, blood electrolyte monitoring, and broader clinical diagnostics, while maintaining a debt-free balance sheet to support R&D and commercialisation.
Average Trading Volume: 174,927
Technical Sentiment Signal: Sell
Current Market Cap: A$76.45M
See more data about AXE stock on TipRanks’ Stock Analysis page.